Perindopril (Coversyl) tablets: New look, same medicine
Perindopril is a long-acting ACE inhibitor for the treatment of hypertension, heart failure, and established coronary artery disease. The Coversyl brand of perindopril has a new look.
New packaging
The packaging for all strengths of Coversyl will change. It is still the same medicine, made by the same company and Medsafe approved.
4 mg strength tablet has changed
The 4 mg tablet has a different shape and colour. It is the same medicine made by the same company.
Packaging for all strengths is changing
When is this happening
By April 2024, it is expected that all Coversyl product with wholesalers will be New Zealand-labelled product.
- Available now: 2 mg Coversyl
- 1 March 2024: 8 mg Coversyl change complete
- 30 April 2024: 4 mg Coversyl packaging and tablets change
Why is this happening?
Since 2021, Coversyl has been dispensed with Canadian packaging. Medsafe had said this could happen until New Zealand packaging was available. New Zealand Coversyl packs are now available.
PDF downloads for pharmacists
- 4 mg Coversyl packaging and tablet change | Feb 24 [PDF 184 KB]
- Coversyl packaging change for all strengths | Feb 24 [PDF 187 KB]
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)